The Valley Desk

NCT01605825 · Interventional trial

A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke

Overall registry status Completed

Phase 2

Conditions Ischemic Stroke

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov